Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Safa Idoudi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Case Reports in Medicine|August 29, 2020
Scalp Necrosis Revealing Severe Giant-Cell ArteritisSafa Idoudi, Marouene Ben Kahla, Fares Mselmi, et al.
Cancer Medicine|March 20, 2025
Real-Life Cohort of Patients With Resected High-Risk Melanoma Treated by Adjuvant Anti-PD1 TherapyLiza Benzoni, Anaïs Eberhardt, Sarah Milley, et al.
Therapie|January 24, 2025
BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort studyEmilien Ezine, Angélique Da Silva, Safa Idoudi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Case Reports in Medicine|August 29, 2020
Scalp Necrosis Revealing Severe Giant-Cell ArteritisSafa Idoudi, Marouene Ben Kahla, Fares Mselmi, et al.
Cancer Medicine|March 20, 2025
Real-Life Cohort of Patients With Resected High-Risk Melanoma Treated by Adjuvant Anti-PD1 TherapyLiza Benzoni, Anaïs Eberhardt, Sarah Milley, et al.
Therapie|January 24, 2025
BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort studyEmilien Ezine, Angélique Da Silva, Safa Idoudi, et al.
Pageof 1